The role of the aromatic amino group in deranged pigment metabolism

[1] ARCHER, 1937, LANCET, V2, P432

[2] BARBOUR, 1938, ARCH INT PHARMACODYN, V58, P78

[3] BINGEL, 1937, HOPPESEYL Z, V250, P57

[4] BROWNLEE, 1939, QUART J PHARM PHARMA, V12, P45

[5] BRUGSCHJT, 1935, Z GES EXP MED, V95, P471

[6] BRUNSTING, 1937, P MAYO CLIN, V12, P609

[7] CABOT, 1902, PHILAD MED J, V10, P848

[8] COLEBROOK, 1937, LANCET, V2, P1237

[9] Colebrook L, 1936, LANCET, V1, P1279

[10] DAKIN, 1922, OXIDATIONS REDUCTION

[1] ARCHER, 1937, LANCET, V2, P432

[2] BARBOUR, 1938, ARCH INT PHARMACODYN, V58, P78

[3] BINGEL, 1937, HOPPESEYL Z, V250, P57

[4] BROWNLEE, 1939, QUART J PHARM PHARMA, V12, P45

[5] BRUGSCHJT, 1935, Z GES EXP MED, V95, P471

[6] BRUNSTING, 1937, P MAYO CLIN, V12, P609

[7] CABOT, 1902, PHILAD MED J, V10, P848

[8] COLEBROOK, 1937, LANCET, V2, P1237

[9] Colebrook L, 1936, LANCET, V1, P1279

[10] DAKIN, 1922, OXIDATIONS REDUCTION